| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.14B | $805.7M | $1.01B |
| YoY Revenue Growth % | +41.6% | -20.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $303.7M | -$64.2M | $241.1M |
| Operating Margin % | 26.6% | -8.0% | 23.9% |
| Net Income (GAAP) | $179.2M | -$138.7M | $123.6M |
| EBITDA (Normalized) | $547.8M | $20.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $280.4M | $115.4M | $260.3M |
| Capital Expenditures (CapEx) | $305.1M | $105.4M | — |
| Free Cash Flow (FCF) | -$24.7M | $10.0M | $260.3M |
| FCF Margin % | -2.2% | 1.2% | 25.8% |
| Return on Invested Capital (ROIC %) | 9.0% | -2.2% | — |
| Cash & Short-Term Equivalents | $248.4M | $81.2M | — |
| Total Debt (Short + Long Term) | $937.7M | $849.8M | — |
| Total Stockholders' Equity | $1.99B | $1.50B | — |